Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin.
Skin barrier damage induces various harmful or even protective reactions in the skin, as represented by enhancement of keratinocyte cytokine production. To investigate whether acute removal of stratum corneum modulates the production of chemokines by epidermal cells, we treated ears of BALB/c and C57BL/6 mice by tape-stripping, or acetone-rubbing as a control of acute barrier disruption procedure. There was no difference between the tape-stripped and acetone-rubbed skin sites in the increased and recovered levels of transepidermal water loss. The mRNA expression levels of all the chemokines tested, including Th1 chemokines (CXCL10, CXCL9 and CXCL11), Th2 chemokines (CCL17 and CCL22) and eosinophil chemoattractant (CCL5), were higher in the epidermal cells from BALB/c than in those of C57BL/6 mice. In particular, CCL17, CCL22 and CCL5 were remarkably elevated in BALB/c mice and augmented by tape-stripping more markedly than acetone-rubbing, whereas Th1 chemokines were enhanced by acetone-rubbing more remarkably. Tape-stripping induced dermal infiltration of eosinophils in BALB/c but not C57BL/6 mice. In a contact hypersensitivity model, where BALB/c mice were sensitized on the abdomen and challenged on the ears with fluorescein isothiocyanate, mice exhibited higher ear swelling responses at the late-phase as well as delayed-type reactions, when challenged via the tape-stripped skin. The challenge via tape-stripped skin augmented the expression of IL-4 and CCR4 in the skin homogenated samples, indicating infiltration of Th2 cells. These findings suggest that acute barrier removal induces the expression of Th2 and eosinophil chemokines by epidermal cells and easily evokes the late phase reaction upon challenge with antigen.
Onoue
Ayako
A
Department of Dermatology, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Japan.
Kabashima
Kenji
K
Kobayashi
Miwa
M
Mori
Tomoko
T
Tokura
Yoshiki
Y
D000096:Acetone / Q000494:pharmacology; D000818:Animals; D002465:Cell Movement / Q000187:drug effects / Q000276:immunology*; D018925:Chemokines / Q000235:genetics / Q000378:metabolism*; D019742:Chemokines, CC / Q000235:genetics / Q000378:metabolism; D019743:Chemokines, CXC / Q000235:genetics; D003877:Dermatitis, Contact / Q000378:metabolism* / Q000473:pathology; D020405:Dermis / Q000473:pathology; D054644:Ear Auricle / Q000187:drug effects / Q000293:injuries / Q000378:metabolism / Q000473:pathology; D004487:Edema / Q000139:chemically induced / Q000473:pathology; D004804:Eosinophils / Q000473:pathology*; D004817:Epidermis / Q000187:drug effects / Q000293:injuries* / Q000378:metabolism* / Q000473:pathology; D004847:Epithelial Cells / Q000378:metabolism; D005260:Female; D016650:Fluorescein-5-isothiocyanate / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects / Q000235:genetics; D007371:Interferon-gamma / Q000235:genetics; D015847:Interleukin-4 / Q000235:genetics; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D054398:Receptors, CCR4 / Q000235:genetics; D012867:Skin / Q000187:drug effects / Q000293:injuries / Q000378:metabolism / Q000473:pathology; D018418:Th2 Cells / Q000378:metabolism / Q000473:pathology*; D014867:Water / Q000378:metabolism
C515355:Ccr4 protein, mouse; D018925:Chemokines; D019742:Chemokines, CC; D019743:Chemokines, CXC; D054398:Receptors, CCR4; D014867:Water; D000096:Acetone; D015847:Interleukin-4; D007371:Interferon-gamma; D016650:Fluorescein-5-isothiocyanate